NICE

News

Report warns of UK's rare disease 'postcode lottery'

There is still a ‘postcode lottery’ for patients getting access to vital rare disease treatments in the UK, according to a new report.

News

Sanofi makes double EU filing for cancer and asthma drugs

But NICE rejects Dupixent in eczema

News

NICE rejects rare eye disease therapy

Other treatment option is disfiguring eyelid operation

Market Access

Row over CF drug funding as NHS rejects Vertex offer

Vertex 'astonished and dismayed' by NHS rejection

News

A NICE yes for latest immunotherapy Bavencio

NICE has recommended Merck KGaA and Pfizer’s Bavencio in previously treated metastatic Merkel Cell Carcinoma, a rare and aggressive form of skin cancer.

News

NHS drug deal could fund vital cystic fibrosis research - Ve...

Vertex wants long-term funding for CF research

Report warns of UK's rare disease 'postcode lottery'

Sanofi makes double EU filing for cancer and asthma drugs

NICE rejects rare eye disease therapy

Row over CF drug funding as NHS rejects Vertex offer

A NICE yes for latest immunotherapy Bavencio

NHS drug deal could fund vital cystic fibrosis research - Ve...

Hengrui gets world-first okay for platelet drug hetrombopag

Discover a new era of healthcare panel engagement: Grounded ...

NICE

Editor's Picks